Methyl 4-(((1,1-dimethylethoxy)carbonyl)amino)-4-piperidinecarboxylate → methyl 4-amino-1-(2'-amino-6',7'-dihydro-5'H-spiro[cyclopentane-1,8'-quinazoline]-4'-yl)piperidine-4-carboxylate
반응식
C(OC([NH:8][C:9]1([C:15]([O:17][CH3:18])=[O:16])[CH2:14][CH2:13][NH:12][CH2:11][CH2:10]1)=O)(C)(C)C.CC1C=CC(S(O[C:30]2[C:39]3[CH2:38][CH2:37][CH2:36][C:35]4([CH2:43][CH2:42][CH2:41][CH2:40]4)[C:34]=3[N:33]=[C:32]([NH2:44])[N:31]=2)(=O)=O)=CC=1>>[NH2:8][C:9]1([C:15]([O:17][CH3:18])=[O:16])[CH2:10][CH2:11][N:12]([C:30]2[C:39]3[CH2:38][CH2:37][CH2:36][C:35]4([CH2:43][CH2:42][CH2:41][CH2:40]4)[C:34]=3[N:33]=[C:32]([NH2:44])[N:31]=2)[CH2:13][CH2:14]1참가 물질
3
반응물 2
생성물 1
실험 절차
The title product was prepared using the procedures outlined in Examples 1G and 1H, substituting methyl 4-(tert-butoxycarbonylamino)piperidine-4-carboxylate (CAS# 115655-44-2) for the product from Example 1D. 1H NMR (300 MHz, CDCl3) δ 4.50 (s, 2 H), 3.74 (s, 3 H), 3.30-3.36 (m, 4 H), 2.45 (t, J=4.58 Hz, 2 H), 2.04-2.21 (m, 4 H), 1.79-1.92 (m, J=4.07 Hz, 2 H), 1.49-1.73 (m, 10 H). MS (DCI+) m/z 360 (M+H).